Secondary hyperparathyroidism in HIV patients: is there any responsibility of highly active antiretroviral therapy?

MLA

Pocaterra, Daria, et al. “Secondary Hyperparathyroidism in HIV Patients: Is There Any Responsibility of Highly Active Antiretroviral Therapy?” AIDS (London, England), vol. 25, no. 11, July 2011, pp. 1430–33. EBSCOhost, https://doi.org/10.1097/QAD.0b013e328349060e.

APA

Pocaterra, D., Carenzi, L., Ricci, E., Minisci, D., Schiavini, M., Meraviglia, P., Bevilacqua, M., Zucchi, P., Bonfanti, P., & Rizzardini, G. (2011). Secondary hyperparathyroidism in HIV patients: is there any responsibility of highly active antiretroviral therapy? AIDS (London, England), 25(11), 1430–1433. https://doi.org/10.1097/QAD.0b013e328349060e

Chicago

Pocaterra, Daria, Laura Carenzi, Elena Ricci, Davide Minisci, Monica Schiavini, Paola Meraviglia, Maurizio Bevilacqua, Patrizia Zucchi, Paolo Bonfanti, and Giuliano Rizzardini. 2011. “Secondary Hyperparathyroidism in HIV Patients: Is There Any Responsibility of Highly Active Antiretroviral Therapy?” AIDS (London, England) 25 (11): 1430–33. doi:10.1097/QAD.0b013e328349060e.